A common bracket fungus, and the source of two purified protein-bound polysaccharides: PSK, developed and licensed as a cancer drug in Japan, and PSP, its Chinese counterpart. Retail turkey tail powder is not either of those things.
Turkey tail is the clearest illustration of why the fruiting-body question matters. PSK, sold as Krestin, has been an approved adjuvant cancer medicine in Japan since the 1970s, covered by national health insurance, with meta-analyses of adjuvant use after gastric and colorectal cancer surgery reporting improved survival. That is a genuine pharmaceutical evidence base — for a purified, protein-bound polysaccharide fraction manufactured to drug specification, given alongside chemotherapy under oncological supervision. A tub of grain-grown turkey tail mycelium bought online is a different substance produced by a different process, and no trial has tested it. The gap between those two things is where almost all turkey tail marketing lives.
PSK and PSP are defined pharmaceutical fractions; retail products vary from measured beta-glucan extracts to unassayed mycelium on grain — a product without this marker may not resemble what was studied.
Regulation: PSK is an approved prescription medicine in Japan and PSP is used in China; neither is approved in the US or Europe. Retail turkey tail is a dietary supplement in the US with no pre-market efficacy review, and marketing it using the PSK oncology literature describes a product the buyer is not receiving.
What the research used
The amounts, forms and durations published trials of Turkey tail and PSK actually administered.
These are the amounts published trials administered — not a recommendation, and not a dose to copy. Trial participants were screened, supervised and given a characterised preparation. What is in a retail bottle is frequently not what was studied, and the amount that suits one person is not general advice.
Studied for PSK as adjuvant therapy after cancer surgery (Japan)
3000 mg
Moderate
PSK, oral, alongside chemotherapy · Months to years
The licensed Japanese protocol, given under oncological supervision with a pharmaceutical-grade fraction. It is not a template for self-supplementation and the material is not available as a supplement.
Studied for Immune parameter study in breast cancer
3000–9000 mg
Not enough
Turkey tail fruiting body powder, daily · 6 weeks
A small phase I dose-escalation study in nine women after radiotherapy. It measured immune cell counts, was not designed to test any clinical outcome, and is frequently cited as though it were.
This is general information about food, not medical advice. It cannot diagnose, treat or replace guidance from a clinician who knows your history.
When it was taken
Each window says whether a trial compared it against an alternative, or whether it is convention and pharmacology. Most timing advice is the second kind.
None of the timings below were directly compared in a trial. They reflect how the research happened to dose, or what the pharmacology implies — which is not the same as a timing being better.
🕐Any time
Not enough
No timing comparison exists for either the pharmaceutical fraction or the supplement. PSK dosing in Japan is divided across the day for tolerability.
Timing was not directly compared. This reflects convention or how the compound behaves in the body, not a trial showing this window works better.
The evidence in depth
Best supported: Not enough
What each association actually rests on, and the papers behind it. A rating describes the state of the research, not how promising the supplement sounds. How we rate evidence.
A small pilot study reported shifts in gut bacterial composition with turkey tail extract. It was tiny and uncontrolled, and the significance of the shifts is unknown.
Not enough evidence. Not enough human research to say anything useful yet.
The purified fractions PSK and PSP alter immune cell populations and, as adjuvant therapy in Japanese and Chinese oncology trials, have been associated with improved survival after gastric and colorectal surgery. That evidence belongs to a prescription pharmaceutical given with chemotherapy, and does not transfer to retail mushroom powder, which has not been tested for any clinical outcome.
What may be going on: PSK is a protein-bound beta-glucan that engages pattern recognition receptors including dectin-1 and TLR4 on innate immune cells.
Not enough evidence. Not enough human research to say anything useful yet.
No source is attached to this association yet, so it is rated not enough evidenceby default. It is listed because people commonly ask about it — not because there is evidence for it.
Things to know
Interactions, contraindications and dose limits, most serious first. Concentrated extracts interact with medication in ways the whole plant does not, so this section carries more weight here than it does on a food page.
Worth knowing
The oncology evidence is for a drug you cannot buy
PSK is a licensed Japanese medicine manufactured to pharmaceutical specification and given alongside chemotherapy. Supplement marketing that cites the PSK survival meta-analyses is attaching a drug's evidence to a food powder. Anyone considering turkey tail during cancer treatment should raise it with their oncologist rather than substitute it for anything.
Worth knowing
Mycelium on grain, and unmeasured beta-glucan
Much retail turkey tail is mycelium grown on sterilised grain and milled with the substrate, which can make the product mostly starch. Independent analyses have found fungal beta-glucan content bearing little relation to labels, and many products report "polysaccharides" — a figure that includes grain starch and is therefore not informative.
Interaction
Not for use alongside cancer therapy without oncology input
Immunomodulating supplements can interact with chemotherapy, immunotherapy and radiotherapy in ways that are not well characterised. This is a conversation for the treating team, not a decision to make from a product page.
Too much
Digestive upset and darkened stool
Nausea, bloating and darkened stool or nails were the effects recorded in the Japanese PSK trials. They are generally mild.